BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11710562)

  • 1. Hepatitis B virus X protein in the proteasome of mammalian cells: defining the targeting domain.
    Chen WN; Oon CJ; Goo KS
    Mol Biol Rep; 2001 Mar; 28(1):31-4. PubMed ID: 11710562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional characterization of interaction between hepatitis B virus X protein and the proteasome complex.
    Zhang Z; Torii N; Furusaka A; Malayaman N; Hu Z; Liang TJ
    J Biol Chem; 2000 May; 275(20):15157-65. PubMed ID: 10748218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome complex as a potential cellular target of hepatitis B virus X protein.
    Huang J; Kwong J; Sun EC; Liang TJ
    J Virol; 1996 Aug; 70(8):5582-91. PubMed ID: 8764072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus core protein stimulates the proteasome-mediated degradation of viral X protein.
    Kim JH; Kang S; Kim J; Ahn BY
    J Virol; 2003 Jul; 77(13):7166-73. PubMed ID: 12805415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex.
    Hu Z; Zhang Z; Doo E; Coux O; Goldberg AL; Liang TJ
    J Virol; 1999 Sep; 73(9):7231-40. PubMed ID: 10438810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit.
    Fischer M; Runkel L; Schaller H
    Virus Genes; 1995; 10(1):99-102. PubMed ID: 7483296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome.
    Sirma H; Weil R; Rosmorduc O; Urban S; Israël A; Kremsdorf D; Bréchot C
    Oncogene; 1998 Apr; 16(16):2051-63. PubMed ID: 9572486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of cellular proteasome activities enhances hepadnavirus replication in an HBX-dependent manner.
    Zhang Z; Protzer U; Hu Z; Jacob J; Liang TJ
    J Virol; 2004 May; 78(9):4566-72. PubMed ID: 15078938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin/proteasome system.
    Magnani M
    Nat Biotechnol; 2000 Aug; 18(8):807. PubMed ID: 10932130
    [No Abstract]   [Full Text] [Related]  

  • 10. Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex.
    Bergametti F; Sitterlin D; Transy C
    J Virol; 2002 Jul; 76(13):6495-501. PubMed ID: 12050362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver.
    Hu Z; Zhang Z; Kim JW; Huang Y; Liang TJ
    J Virol; 2006 Feb; 80(3):1405-13. PubMed ID: 16415018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biological effects of COOH-terminal amino acid deletions of hepatitis B virus X protein on hepatocellular carcinoma cell line Huh7].
    Liu XH; Zhu MH; Cao XZ; Zheng JM; Chen Y
    Ai Zheng; 2005 Oct; 24(10):1213-9. PubMed ID: 16219135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus X protein induces cell death by causing loss of mitochondrial membrane potential.
    Shirakata Y; Koike K
    J Biol Chem; 2003 Jun; 278(24):22071-8. PubMed ID: 12676947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus X protein modulates peroxisome proliferator-activated receptor gamma through protein-protein interaction.
    Choi YH; Kim HI; Seong JK; Yu DY; Cho H; Lee MO; Lee JM; Ahn YH; Kim SJ; Park JH
    FEBS Lett; 2004 Jan; 557(1-3):73-80. PubMed ID: 14741344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo.
    Molinari E; Gilman M; Natesan S
    EMBO J; 1999 Nov; 18(22):6439-47. PubMed ID: 10562555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of functionally important amino acid residues in the mitochondria targeting sequence of hepatitis B virus X protein.
    Li SK; Ho SF; Tsui KW; Fung KP; Waye MY
    Virology; 2008 Nov; 381(1):81-8. PubMed ID: 18805561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Turnover of hepatitis B virus X protein is facilitated by Hdj1, a human Hsp40/DnaJ protein.
    Sohn SY; Kim JH; Baek KW; Ryu WS; Ahn BY
    Biochem Biophys Res Commun; 2006 Sep; 347(3):764-8. PubMed ID: 16842747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocystin/80K-H inhibits replication of hepatitis B virus through interaction with HBx protein in hepatoma cell.
    Shin GC; Ahn SH; Choi HS; Lim KH; Choi DY; Kim KP; Kim KH
    Biochim Biophys Acta; 2013 Oct; 1832(10):1569-81. PubMed ID: 23644164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregate formation of hepatitis B virus X protein affects cell cycle and apoptosis.
    Song CZ; Bai ZL; Song CC; Wang QW
    World J Gastroenterol; 2003 Jul; 9(7):1521-4. PubMed ID: 12854155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E3 ubiquitin ligase Siah-1 facilitates poly-ubiquitylation and proteasomal degradation of the hepatitis B viral X protein.
    Zhao J; Wang C; Wang J; Yang X; Diao N; Li Q; Wang W; Xian L; Fang Z; Yu L
    FEBS Lett; 2011 Oct; 585(19):2943-50. PubMed ID: 21878328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.